Header cover image

Saudi Arabian (Tadawul) Pharma Industry Analysis

UpdatedMar 09, 2025
DataAggregated Company Financials
Companies3
  • 7D-7.0%
  • 3M0.7%
  • 1Y-3.9%
  • YTD1.0%

Over the last 7 days, the Pharma industry has dropped 7.0%, driven by declines from every company within the industry. The industry has fallen 3.9% in the last year. Earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the Saudi Arabian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 10 Mar 2025ر.س17.2bر.س3.3bر.س460.2m32.7x37.3x5.1x
Wed, 05 Feb 2025ر.س18.1bر.س3.3bر.س453.1m33.3x39.9x5.5x
Fri, 03 Jan 2025ر.س16.7bر.س3.3bر.س453.1m30.1x36.8x5.1x
Sun, 01 Dec 2024ر.س17.0bر.س3.3bر.س453.1m31.5x37.5x5.2x
Tue, 29 Oct 2024ر.س18.2bر.س3.2bر.س393.5m34.4x46.4x5.8x
Thu, 26 Sep 2024ر.س20.4bر.س3.2bر.س393.5m38.1x51.9x6.5x
Sat, 24 Aug 2024ر.س18.3bر.س3.2bر.س393.5m34.5x46.4x5.8x
Mon, 22 Jul 2024ر.س16.5bر.س3.1bر.س346.2m33.9x47.6x5.2x
Wed, 19 Jun 2024ر.س15.8bر.س3.1bر.س346.2m32.5x45.7x5x
Fri, 17 May 2024ر.س16.9bر.س3.1bر.س338.0m37.8x50x5.5x
Sun, 14 Apr 2024ر.س16.5bر.س3.1bر.س338.0m39.6x48.9x5.3x
Tue, 12 Mar 2024ر.س17.7bر.س3.1bر.س268.3m47.8x65.9x5.7x
Thu, 08 Feb 2024ر.س14.1bر.س2.8bر.س209.0m35.6x67.3x5.1x
Sat, 06 Jan 2024ر.س12.6bر.س2.8bر.س209.0m28.5x60.1x4.5x
Mon, 04 Dec 2023ر.س12.4bر.س2.8bر.س209.0m28.6x59.1x4.4x
Wed, 01 Nov 2023ر.س11.2bر.س2.7bر.س173.3m30.5x64.5x4.1x
Fri, 29 Sep 2023ر.س12.4bر.س2.7bر.س173.3m32.7x71.4x4.6x
Sun, 27 Aug 2023ر.س12.6bر.س2.7bر.س182.9m32.5x69x4.7x
Tue, 25 Jul 2023ر.س13.7bر.س2.5bر.س68.4m42.8x200x5.4x
Thu, 22 Jun 2023ر.س11.3bر.س2.5bر.س27.5m36.9x409.5x4.5x
Sat, 20 May 2023ر.س3.7bر.س1.6b-ر.س139,134,012.00n/a-26.5x2.3x
Mon, 17 Apr 2023ر.س3.0bر.س1.4b-ر.س164,134,012.00n/a-18x2.1x
Wed, 15 Mar 2023ر.س2.8bر.س1.4b-ر.س93,914,095.00n/a-29.8x2x
Fri, 10 Feb 2023ر.س2.7bر.س1.4b-ر.س93,914,095.00n/a-28.6x1.9x
Sun, 08 Jan 2023ر.س2.7bر.س1.4b-ر.س93,914,095.00n/a-28.4x1.9x
Tue, 06 Dec 2022ر.س2.8bر.س1.4b-ر.س93,914,095.00n/a-29.3x1.9x
Thu, 03 Nov 2022ر.س3.1bر.س1.4b-ر.س41,687,503.00n/a-74.4x2.2x
Sat, 01 Oct 2022ر.س3.1bر.س1.4b-ر.س41,687,503.00n/a-75.3x2.3x
Mon, 29 Aug 2022ر.س3.4bر.س1.4b-ر.س45,033,318.00n/a-75.5x2.4x
Wed, 27 Jul 2022ر.س3.3bر.س1.5bر.س37.6m86.7x86.7x2.2x
Fri, 24 Jun 2022ر.س3.3bر.س1.5bر.س37.6m86.5x86.5x2.2x
Sun, 22 May 2022ر.س4.0bر.س1.5bر.س29.7m133.2x133.2x2.7x
Tue, 19 Apr 2022ر.س4.5bر.س1.5bر.س29.7m151.1x151.1x3.1x
Thu, 17 Mar 2022ر.س4.5bر.س1.5bر.س54.2m82.2x82.2x3x
Price to Earnings Ratio

82.2x


Total Market Cap: ر.س4.5bTotal Earnings: ر.س54.2mTotal Revenue: ر.س1.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Saudi Arabian Pharma Industry Price to Earnings3Y Average 46.7x202320242025
Current Industry PE
    There are only 3 companies in the Saudi Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 104% per year over the last three years.
  • Revenues for these companies have grown 31% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Saudi Arabian Healthcare industry?

SA Market-3.04%
Healthcare-5.68%
Pharma-6.97%
Pharma-6.97%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.